Your browser doesn't support javascript.
loading
Loss of Sucrase-Isomaltase Function Increases Acetate Levels and Improves Metabolic Health in Greenlandic Cohorts.
Andersen, Mette K; Skotte, Line; Jørsboe, Emil; Polito, Ryan; Stæger, Frederik F; Aldiss, Peter; Hanghøj, Kristian; Waples, Ryan K; Santander, Cindy G; Grarup, Niels; Dahl-Petersen, Inger K; Diaz, Lars J; Overvad, Maria; Senftleber, Ninna K; Søborg, Bolette; Larsen, Christina V L; Lemoine, Clara; Pedersen, Oluf; Feenstra, Bjarke; Bjerregaard, Peter; Melbye, Mads; Jørgensen, Marit E; Færgeman, Nils J; Koch, Anders; Moritz, Thomas; Gillum, Matthew P; Moltke, Ida; Hansen, Torben; Albrechtsen, Anders.
Afiliação
  • Andersen MK; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Skotte L; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Jørsboe E; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Section for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
  • Polito R; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Stæger FF; Section for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
  • Aldiss P; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Hanghøj K; Section for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
  • Waples RK; Section for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
  • Santander CG; Section for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen, Denmark.
  • Grarup N; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Dahl-Petersen IK; National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Diaz LJ; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Overvad M; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Senftleber NK; Section for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen, Denmark; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Søborg B; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Larsen CVL; National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark; Greenland Centre for Health Research, University of Greenland, Nuuk, Greenland.
  • Lemoine C; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Pedersen O; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Feenstra B; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Bjerregaard P; National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.
  • Melbye M; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Medicine, Stanford University School of Medicine, Stanford, California.
  • Jørgensen ME; National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark; Steno Diabetes Center Copenhagen, Gentofte, Denmark; Greenland Centre for Health Research, University of Greenland, Nuuk, Greenland.
  • Færgeman NJ; Department of Biochemistry and Molecular Biology, Villum Center for Bioanalytical Sciences, University of Southern Denmark, Odense, Denmark.
  • Koch A; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark; Greenland Centre for Health Research, University of Greenland, Nuuk, Greenland; Department of Infectious Diseases, Rigshospitalet University Hospital, Copenhagen, Denmark.
  • Moritz T; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Gillum MP; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Moltke I; Section for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen, Denmark. Electronic address: ida@binf.ku.dk.
  • Hansen T; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. Electronic address: torben.hansen@sund.ku.dk.
  • Albrechtsen A; Section for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen, Denmark. Electronic address: albrecht@binf.ku.dk.
Gastroenterology ; 162(4): 1171-1182.e3, 2022 04.
Article em En | MEDLINE | ID: mdl-34914943
ABSTRACT
BACKGROUND &

AIMS:

The sucrase-isomaltase (SI) c.273_274delAG loss-of-function variant is common in Arctic populations and causes congenital sucrase-isomaltase deficiency, which is an inability to break down and absorb sucrose and isomaltose. Children with this condition experience gastrointestinal symptoms when dietary sucrose is introduced. We aimed to describe the health of adults with sucrase-isomaltase deficiency.

METHODS:

The association between c.273_274delAG and phenotypes related to metabolic health was assessed in 2 cohorts of Greenlandic adults (n = 4922 and n = 1629). A sucrase-isomaltase knockout (Sis-KO) mouse model was used to further elucidate the findings.

RESULTS:

Homozygous carriers of the variant had a markedly healthier metabolic profile than the remaining population, including lower body mass index (ß [standard error], -2.0 [0.5] kg/m2; P = 3.1 × 10-5), body weight (-4.8 [1.4] kg; P = 5.1 × 10-4), fat percentage (-3.3% [1.0%]; P = 3.7 × 10-4), fasting triglyceride (-0.27 [0.07] mmol/L; P = 2.3 × 10-6), and remnant cholesterol (-0.11 [0.03] mmol/L; P = 4.2 × 10-5). Further analyses suggested that this was likely mediated partly by higher circulating levels of acetate observed in homozygous carriers (ß [standard error], 0.056 [0.002] mmol/L; P = 2.1 × 10-26), and partly by reduced sucrose uptake, but not lower caloric intake. These findings were verified in Sis-KO mice, which, compared with wild-type mice, were leaner on a sucrose-containing diet, despite similar caloric intake, had significantly higher plasma acetate levels in response to a sucrose gavage, and had lower plasma glucose level in response to a sucrose-tolerance test.

CONCLUSIONS:

These results suggest that sucrase-isomaltase constitutes a promising drug target for improvement of metabolic health, and that the health benefits are mediated by reduced dietary sucrose uptake and possibly also by higher levels of circulating acetate.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complexo Sacarase-Isomaltase / Sacarose Alimentar Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complexo Sacarase-Isomaltase / Sacarose Alimentar Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article